why choose us

First received: December 05, 2023

Clinical Trial: Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hyperuricemia

Study Type: INTERVENTIONAL


Official Title: Bioequivalence Study of 2 Sizes of SHR4640 Tablets in Healthy Subjects (Randomized, Open, Single Dose, Two Sequences, Two Cycles, Self-Crossover Control)

Brief Summary: The study is being conducted to evaluate the pharmacokinetic, and safety of two sizes of SHR4640 tablets in healthy adults, to explore the bioequivalence between two sizes of SHR4640 tablets.

Read more